HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice.

AbstractBACKGROUND:
We imaged the protease activity of matrix metalloproteinases (MMPs) upregulated during aneurysm formation, using protease-activatable near-infrared fluorescence probes. We tested whether these protease-activatable sensors can directly report the in vivo activity of the key biomarkers in aneurysm, using our genetically modified fibulin-4 mouse models for aneurysm formation. Mice homozygous for the fibulin-4 reduced-expression allele (fibulin-4(R/R)) show dilatation of the ascending aorta and a tortuous, stiffened aorta resulting from disorganized elastic fiber networks. Strikingly, even a moderate reduction in expression of fibulin-4 in the heterozygous fibulin-4(+/R) mice occasionally results in modest aneurysm formation.
METHODS AND RESULTS:
Aorta transcriptome and protein expression analysis of fibulin-4(+/R) and fibulin-4(R/R) animals identified excessive transforming growth factor-β signaling as the critical event in the pathogenesis of aneurysm formation. To determine whether a perturbed elastin lamellar structure arose from induction of transforming growth factor-β-regulated MMPs, we performed gelatin zymography and used a protease-activatable near-infrared fluorescence probe to monitor and quantify MMP upregulation in animals, using various in vivo optical imaging modules and coregistration of the fluorescence signal with CT images of the same animals. Gelatin zymography demonstrated a significant increase in the presence of the active form of MMP-9 in the aortic arch of fibulin-4(R/R) mice. In vivo analysis of MMP upregulation using the near-infrared fluorescence probe and subsequent isosurface concentration mapping from reconstructed tomographic images from fibulin-4(+/R) and fibulin-4(R/R) mice revealed a graded increase in activation of MMPs within the aneurysmal lesions.
CONCLUSIONS:
We aimed to develop molecular imaging procedures for faster, earlier, and easier recognition of aortic aneurysms. We show that in vivo coregistration of MMP activity by noninvasive tomographic imaging methods allows the detection of increased MMP activity, even before the aneurysm has actually formed.
AuthorsEric L Kaijzel, Paula M van Heijningen, Piotr A Wielopolski, Marcel Vermeij, Gerben A Koning, Wiggert A van Cappellen, Ivo Que, Alan Chan, Jouke Dijkstra, Natasja W M Ramnath, Lukas J A C Hawinkels, Monique R Bernsen, Clemens W G M Löwik, Jeroen Essers
JournalCirculation. Cardiovascular imaging (Circ Cardiovasc Imaging) Vol. 3 Issue 5 Pg. 567-77 (Sep 2010) ISSN: 1942-0080 [Electronic] United States
PMID20592247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • EFEMP2 protein, human
  • Extracellular Matrix Proteins
  • Transforming Growth Factor beta
  • Elastin
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse
Topics
  • Animals
  • Aorta, Thoracic (diagnostic imaging, enzymology, pathology)
  • Aortic Aneurysm, Thoracic (diagnosis, enzymology, genetics)
  • Aortography (methods)
  • Biomarkers (metabolism)
  • Biosensing Techniques
  • Disease Models, Animal
  • Disease Progression
  • Early Diagnosis
  • Elastin
  • Enzyme Activation
  • Extracellular Matrix Proteins (deficiency, genetics, metabolism)
  • Fluorescence
  • Magnetic Resonance Angiography
  • Matrix Metalloproteinase 9 (metabolism)
  • Matrix Metalloproteinases (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Molecular Imaging (methods)
  • Predictive Value of Tests
  • Signal Transduction
  • Spectroscopy, Near-Infrared
  • Tomography, X-Ray Computed
  • Transforming Growth Factor beta (metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: